Cargando…

Undiagnosed sleep apnea in patients with atrial fibrillation: An underutilized opportunity for antiarrhythmic management

Detalles Bibliográficos
Autores principales:	Hereijgers, Maartje J.M., Betz, Konstanze, Simons, Sami O., Linz, Dominik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157447/ https://www.ncbi.nlm.nih.gov/pubmed/35663454 http://dx.doi.org/10.1016/j.ijcha.2022.101050

Ejemplares similares

Sleep apnea and atrial fibrillation: Update 2020
por: Linz, Dominik, et al.
Publicado: (2020)

Obstructive respiratory events during procedural sedation and analgesia: Another WHY to routinely screen for sleep apnea before catheter ablation of atrial fibrillation
por: Linz, Dominik, et al.
Publicado: (2021)

Central sleep apnea in atrial fibrillation: Risk factor or marker of untreated underlying disease?
por: Linz, Dominik, et al.
Publicado: (2020)

Obstructive Sleep Apnea and Atrial Arrhythmogenesis
por: Hohl, Mathias, et al.
Publicado: (2014)

Personalized management of sleep apnea in patients with atrial fibrillation: An interdisciplinary and translational challenge
por: Linz, Dominik, et al.
Publicado: (2021)

Sleep apnea in atrial fibrillation – Highly prevalent, highly relevant, but most patients are not somnolent!
por: Kadhim, Kadhim, et al.
Publicado: (2020)

Emerging Antiarrhythmic Drugs for Atrial Fibrillation
por: Saljic, Arnela, et al.
Publicado: (2022)

Atrial fibrillation-specific refinement of the STOP-Bang sleep apnoea screening questionnaire: insights from the Virtual-SAFARI study
por: Betz, Konstanze, et al.
Publicado: (2023)

Nightly sleep apnea severity in patients with atrial fibrillation: Potential applications of long-term sleep apnea monitoring
por: Linz, Dominik, et al.
Publicado: (2019)

Impact of undiagnosed obstructive sleep apnea on atrial fibrillation recurrence following catheter ablation (OSA-AF study)()
por: de Heide, John, et al.
Publicado: (2022)

Obstructive sleep apnea and atrial fibrillation
por: Todd, Keith, et al.
Publicado: (2010)

Obstructive Sleep Apnea and Atrial Fibrillation
por: Moula, Amalia Ioanna, et al.
Publicado: (2022)

Sleeping Beauty unravelled – Detection of sleep apnoea in patients with atrial fibrillation
por: Hendriks, Jeroen M., et al.
Publicado: (2023)

Antiarrhythmic drugs for atrial fibrillation: Imminent impulses are emerging
por: Dan, Gheorghe-Andrei, et al.
Publicado: (2018)

Oral Anticoagulation and Antiarrhythmic Drug Therapy for Atrial Fibrillation
por: Reiffel, James A.
Publicado: (2018)

Repurposing catheter ablation work-up to detect expiratory airflow limitation in patients with atrial fibrillation()
por: Hereijgers, Maartje J.M., et al.
Publicado: (2023)

Atrial fibrillation-specific refinement of the STOP-Bang sleep apnoea screening questionnaire: Insights from the Virtual-SAFARI study
por: Verhaert, D V M, et al.
Publicado: (2023)

Implementation of a screening and management pathway for chronic obstructive pulmonary disease in patients with atrial fibrillation
por: van der Velden, Rachel M J, et al.
Publicado: (2023)

Implementation of a screening and management pathway for chronic obstructive pulmonary disease in patients with atrial fibrillation
por: Van Der Velden, R, et al.
Publicado: (2023)

Obstructive Sleep Apnea Screening in Patients With Atrial Fibrillation: Missed Opportunities for Early Diagnosis
por: Khan, Asif, et al.
Publicado: (2019)

Sleep Apnea and Atrial Fibrillation; 2012 Update
por: Digby, Genevieve C, et al.
Publicado: (2012)

Extended use of preprocedural data to detect expiratory airflow limitation in patients with atrial fibrillation scheduled for ablation
por: Hereijgers, M J M, et al.
Publicado: (2023)

Prior antiarrhythmic drug use and the outcome of atrial fibrillation ablation
por: Winkle, Roger A., et al.
Publicado: (2012)

Pleiotropic Effects of Antiarrhythmic Agents: Dronedarone in the Treatment of Atrial Fibrillation
por: Heijman, Jordi, et al.
Publicado: (2013)

Computational Modeling for Antiarrhythmic Drugs for Atrial Fibrillation According to Genotype
por: Hwang, Inseok, et al.
Publicado: (2021)

The Interplay between Obstructive Sleep Apnea and Atrial Fibrillation
por: Marulanda-Londoño, Erika, et al.
Publicado: (2017)

Efficacy of class III antiarrhythmics and magnesium combination therapy for atrial fibrillation
por: Wang, Amy
Publicado: (2012)

Time‐dependent antiarrhythmic effects of flecainide on induced atrial fibrillation in horses
por: Carstensen, Helena, et al.
Publicado: (2018)

Knots to untie: anticoagulant and antiarrhythmic therapy after ablation for atrial fibrillation
por: Stazi, Filippo
Publicado: (2020)

Corrigendum: Computational modeling for antiarrhythmic drugs for atrial fibrillation according to genotype
por: Hwang, Inseok, et al.
Publicado: (2022)

Good News: Family Medicine Specialists Have More Opportunity to Diagnose Undiagnosed Sleep Apnea in Children
por: Chidambaram, Ramasamy
Publicado: (2018)

360° Virtual reality to improve patient education and reduce anxiety towards atrial fibrillation ablation
por: Hermans, Astrid N L, et al.
Publicado: (2023)

Atrial Tachycardias Arising from Ablation of Atrial Fibrillation: A Proarrhythmic Bump or an Antiarrhythmic Turn?
por: Shah, Ashok J., et al.
Publicado: (2010)

Effects of antiarrhythmics on atrial high rate episodes and progression to clinical atrial fibrillation (ANTI-AHRE)
por: Simovic, S, et al.
Publicado: (2023)

No atrial fibrillation, no histologic findings but even no obstructive sleep apnea?
por: Keymel, Stefanie, et al.
Publicado: (2015)

Cardioversion of atrial fibrillation does not affect obstructive sleep apnea
por: Höglund, Niklas, et al.
Publicado: (2017)

Sleep apnea and atrial fibrillation – A different kind of rhythm
por: Sousa, Susana, et al.
Publicado: (2020)

Mechanism and management of atrial fibrillation in the patients with obstructive sleep apnea
por: Iwasaki, Yu‐ki
Publicado: (2022)

Antiarrhythmic and Electrophysiologic Effects of Flecainide on Acutely Induced Atrial Fibrillation in Healthy Horses
por: Haugaard, M.M., et al.
Publicado: (2014)

Pulmonary Delivery of Antiarrhythmic Drugs for Rapid Conversion of New-Onset Atrial Fibrillation
por: Verrier, Richard L., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0tqjhigo83bichb2bftkbmvm3r